Recurrent UTI in Menopause
Is It Really Genitourinary Syndrome of Menopause?
By Desirae Bloomquist, FNP-C — Founder, Heat Wave Health
Recurrent UTIs in Midlife Women: When It’s Not an Infection, It’s Genitourinary Syndrome of Menopause
If you are over 40 and experiencing frequent urinary tract infections, you are not alone.
Many women in perimenopause and menopause are prescribed antibiotics repeatedly, sometimes even placed on daily preventative antibiotics, for what appears to be recurrent UTI.
But in many cases, the root cause is not infection.
It is genitourinary syndrome of menopause (GSM).
And treating GSM with antibiotics alone misses the underlying physiology entirely.
What Is Genitourinary Syndrome of Menopause (GSM)?
Genitourinary syndrome of menopause is a chronic condition caused by declining estrogen levels affecting the vulva, vagina, urethra, and bladder.
Estrogen receptors are abundant throughout the lower urinary tract. When estrogen declines during the menopause transition:
- Vaginal tissue thins
- The urethral lining becomes fragile
- Collagen and elasticity decrease
- The vaginal microbiome shifts
- Protective lactobacillus levels decline
- Vaginal pH rises
These changes create an environment where urinary symptoms become common. Even in the absence of true infection.
According to the North American Menopause Society (NAMS) 2022 position statement on genitourinary syndrome of menopause, GSM is common, under diagnosed, and frequently under treated.
Why GSM Feels Like a UTI
Women with GSM often experience:
- Burning with urination
- Urinary urgency
- Increased frequency
- Bladder pressure
- Recurrent “UTI-like” symptoms
- Pain with intercourse
- Vaginal dryness
Sometimes urine cultures are positive. Sometimes they are negative.
But the underlying issue is frequently estrogen deficiency affecting the urogenital tissues, not simply bacterial overgrowth.
The Problem With Repeated Antibiotics
When urinary symptoms are treated as infection every time, women may receive:
- Multiple antibiotic courses per year
- Prophylactic daily antibiotics
- Broad-spectrum antibiotics without culture confirmation
This approach can lead to antibiotic resistance, gut microbiome disruption, increased yeast infections, and persistent recurrence of symptoms.
Antibiotics treat bacteria. They do not repair estrogen-deprived tissue.
If the tissue environment remains atrophic and inflamed, symptoms often return, leading to another prescription and another cycle.
Vaginal Estrogen: The Missing Treatment in Recurrent UTI
Both NAMS and the American College of Obstetricians and Gynecologists (ACOG) recognize low-dose vaginal estrogen therapy as first-line treatment for GSM and as an effective strategy for reducing recurrent urinary tract infections in postmenopausal women.
Local estrogen therapy:
- Restores vaginal tissue thickness
- Improves urethral integrity
- Lowers vaginal pH
- Promotes healthy lactobacillus growth
- Reduces urinary urgency and frequency
- Decreases recurrent UTI risk
Low-dose vaginal estrogen is considered safe for most women and carries minimal systemic absorption.
For many women, this is the treatment that actually breaks the cycle.
When Systemic Hormone Therapy May Also Help
In some women, especially those with additional menopause symptoms such as hot flashes, sleep disruption, or mood changes, systemic menopause hormone therapy may be appropriate alongside local vaginal estrogen.
The correct treatment depends on symptom profile, stage of menopause, medical history, and risk assessment.
This is why individualized menopause care matters.
The Bottom Line
Frequent urinary tract infections during perimenopause and menopause are common.
But repeated antibiotics are not always the answer.
Genitourinary syndrome of menopause is a chronic, progressive condition driven by estrogen decline. Without restoring hormonal support to the urogenital tissues, symptoms often persist.
When we treat the physiology, not just the bacteria, outcomes improve.
And many women finally break the cycle of recurrent UTI.
References
North American Menopause Society. The 2022 Hormone Therapy Position Statement of The North American Menopause Society. Menopause. 2022;29(7):767-794. (Includes guidance on genitourinary syndrome of menopause and use of vaginal estrogen.)
American College of Obstetricians and Gynecologists. Treatment of Urogenital Symptoms in Individuals With a History of Estrogen-Dependent Breast Cancer. Clinical Consensus No. 2. Obstet Gynecol. 2021;138(6):1131-1144.
(Addresses safety and efficacy of low-dose vaginal estrogen for genitourinary syndrome of menopause and recurrent urinary symptoms.)
Author’s Note
If you’ve been treated repeatedly for UTIs without lasting relief, you’re not imagining the pattern.
In midlife, recurrent urinary symptoms are often hormonal, not just infectious. Genitourinary syndrome of menopause is common, underdiagnosed, and highly treatable when addressed correctly.
You don’t have to continue cycling through antibiotics. There are evidence-based solutions that address the underlying cause.
If this sounds familiar, it may be time for a more comprehensive, menopause-informed approach.
Desirae Bloomquist, FNP — Founder, Heat Wave Health